Overview
Minocher Battiwalla is a Hematologist Oncology specialist and a Hematologist in Bowling Green, Kentucky. Dr. Battiwalla is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Battiwalla is currently accepting new patients.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
700 1st Ave, Bowling Green, KY 42101
2410 Patterson St, Suite 500, Nashville, TN 37203
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Sarah Cannon Research Institute
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
John Greer is a Hematologist in Nashville, Tennessee. Dr. Greer is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Tennessee Oncology PLLC
Michael Byrne is a Hematologist and a Hematologist Oncology provider in Nashville, Tennessee. Dr. Byrne is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Byrne is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia with MaturationDr. Battiwalla isDistinguished. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Battiwalla isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Battiwalla isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndrome (MDS)Dr. Battiwalla isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Battiwalla isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Bone Marrow AspirationDr. Battiwalla isAdvanced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Battiwalla isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Battiwalla isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Myelomonocytic Leukemia (CMML)Dr. Battiwalla isAdvanced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Febrile NeutropeniaDr. Battiwalla isAdvanced. Learn about Febrile Neutropenia.
- Experienced
- Acute Myelomonocytic LeukemiaDr. Battiwalla isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Battiwalla isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Battiwalla isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Battiwalla isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Battiwalla isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Battiwalla isExperienced. Learn about Aplastic Anemia.